# Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

> **NCT00383383** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 141 (—)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** Hepatitis B adjuvanted vaccine
- **BIOLOGICAL:** Engerix-B

## Key facts

- **NCT ID:** NCT00383383
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 141 (—)
- **Last updated:** 2006-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00383383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00383383, "Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00383383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*